🎈 Up Big Today: Find today's biggest gainers with our free screenerTry Stock Screener

Avantor Inc (AVTR)

NYSE
Currency in USD
22.66
+0.22(+0.98%)
Closed
After Hours
22.37-0.28(-1.24%)
AVTR Scorecard
Full Analysis
Net income is expected to grow this year
Fair Value
Day's Range
22.3922.79
52 wk Range
19.5928.00
Key Statistics
Edit
Prev. Close
22.66
Open
22.47
Day's Range
22.39-22.79
52 wk Range
19.59-28
Volume
5.81M
Average Volume (3m)
6.03M
1-Year Change
6.54%
Book Value / Share
8.17
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AVTR Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
27.31
Upside
+20.52%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week
Show more

Avantor Company Profile

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Avantor Inc SWOT Analysis


Bioprocessing Boom
Avantor's strategic focus on bioprocessing positions it for growth, with expectations to exit 2024 at mid-high single digits, aligning with long-term market projections
Margin Mastery
Cost-saving initiatives yield positive results, with Avantor aiming for a 20% EBITDA margin by 2025, showcasing commitment to operational efficiency
Market Challenges
Explore how Avantor navigates industry-wide destocking and semiconductor market softness while maintaining steady performance in Laboratory Solutions
Analyst Outlook
Price targets range from $25 to $34, with an average of $29.71, reflecting varied perspectives on Avantor's growth potential amid market complexities
Read full SWOT analysis
AVTR Full Pro Research
Institutional-Grade Stock Analysis
Understand how AVTR earns money
Financial health at a glance
Bearish and bullish outlooks
Latest expert insights
Actionable Pro Tips, and many more...
Gain access to 1400+ in-depth research reports on the most popular US stocks

Avantor Inc Earnings Call Summary for Q4/2024

  • Q3 revenue at $1.71B with 0.7% organic decline; adjusted EPS up to $0.26; clinical services divestiture to reduce debt
  • Lab Solutions revenue up 0.6% YoY; Bioscience Production down 3.5% organically; free cash flow guidance raised to over $750M
  • Full-year organic growth guidance unchanged at -2% to +1%; adjusted EBITDA margin projected 17.3-17.8%; adjusted EPS $0.95-$1.03
  • Mid to high single-digit growth expected in bioprocessing for Q4; company on track to exceed $100M cost savings target for the year
  • Lab business returns to growth; strong bioprocessing orders; management confident in achieving 20% EBITDA margin exit rate for 2025
Last Updated: 26-10-2024, 03:06 am
Read Full Transcript

Compare AVTR to Peers and Sector

Metrics to compare
AVTR
Peers
Sector
Relationship
P/E Ratio
49.8x−4.8x−0.6x
PEG Ratio
−2.930.090.00
Price/Book
2.8x1.8x2.6x
Price / LTM Sales
2.3x2.4x3.2x
Upside (Analyst Target)
20.3%22.6%40.6%
Fair Value Upside
Unlock10.0%7.1%Unlock

Analysts' Recommendations

16 Buy
6 Hold
0 Sell
Ratings:
19 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 27.31

(+20.50% Upside)

FAQ

What Is the Avantor (AVTR) Stock Price Today?

The Avantor stock price today is 22.66.

What Stock Exchange Does Avantor Trade On?

Avantor is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for Avantor?

The stock symbol for Avantor is "AVTR."

What Is the Avantor Market Cap?

As of today, Avantor market cap is 15.42B.

What is Avantor Earnings Per Share?

The Avantor EPS is 0.456.

What Is the Next Avantor Earnings Date?

Avantor will release its next earnings report on 29 Jan 2025.

From a Technical Analysis Perspective, Is AVTR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.